ProfileGDS5822 / ILMN_1244141
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 9% 33% 60% 19% 26% 2% 35% 38% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 19.89
GSM1276600PDAC Late Ablation Control 218.233
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 12660
GSM1276603PDAC Late Ablation 211.719
GSM1276604PDAC Late Ablation 314.326
GSM1303940PDAC Late Ablation_anti-CTLA4 14.72
GSM1303941PDAC Late Ablation_anti-CTLA4 216.635
GSM1303942PDAC Late Ablation_anti-CTLA4 318.238